1. Home
  2. IBRX vs CVLT Comparison

IBRX vs CVLT Comparison

Compare IBRX & CVLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ImmunityBio Inc.

IBRX

ImmunityBio Inc.

N/A

Current Price

$8.24

Market Cap

8.2B

Sector

Health Care

ML Signal

N/A

Logo Commvault Systems Inc.

CVLT

Commvault Systems Inc.

N/A

Current Price

$165.56

Market Cap

7.0B

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
IBRX
CVLT
Founded
2014
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
8.2B
7.0B
IPO Year
2015
2006

Fundamental Metrics

Financial Performance
Metric
IBRX
CVLT
Price
$8.24
$165.56
Analyst Decision
Strong Buy
Buy
Analyst Count
4
19
Target Price
$14.25
★ $189.38
AVG Volume (30 Days)
★ 13.5M
643.0K
Earning Date
11-10-2026
10-27-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 38.71
N/A
EPS
N/A
★ 1.19
Revenue
$113,288,000.00
★ $1,183,690,000.00
Revenue This Year
$99.98
$10.38
Revenue Next Year
$108.29
$7.06
P/E Ratio
★ N/A
$144.24
Revenue Growth
★ 668.31
18.89
52 Week Low
$1.95
$71.75
52 Week High
$12.43
$174.25

Technical Indicators

Market Signals
Indicator
IBRX
CVLT
Relative Strength Index (RSI) 43.83 56.95
Support Level $7.71 $144.07
Resistance Level $8.51 N/A
Average True Range (ATR) 0.71 8.40
MACD -0.13 0.51
Stochastic Oscillator 18.18 67.90

Price Performance

Historical Comparison
IBRX
CVLT

About IBRX ImmunityBio Inc.

ImmunityBio Inc is a biotechnology company focused on developing and commercializing next-generation immunotherapies designed to activate the patient's immune system and provide durable protection against cancer and infectious diseases. Its approach harnesses both the adaptive and innate immune systems with the Cancer BioShield platform. The platform is built around the proprietary IL-15 superagonist ANKTIVA (nogapendekin alfa inbakicept) and is supported by a portfolio that includes adenovirus-vectored vaccines, NK-cell therapies, and additional immunomodulators. The company operates in the United States and Europe, with the majority of its revenue coming from the United States.

About CVLT Commvault Systems Inc.

CommVault Systems Inc provides cyber resiliency solutions designed to help the enterprise protect, secure, and recover its data, applications, and identity systems in a world of increasing cyber threats and attacks. Its offerings provide cyber resilience, including data protection, cyber recovery, data security, and governance, aiming to enable customers to continue business. The company delivers its solutions through Commvault Cloud, a cloud native platform that unifies data security, cyber recovery and identity resilience across on-premises, hybrid, multi-cloud, and software-as-a-service environments. It sells its offerings through subscription-based arrangements, including SaaS and term-based subscriptions, and also offers perpetual licenses, customer support, and professional services.

Share on Social Networks: